Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.50 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.47 |
| ▸ | GNPAT | O15228 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | NPY1R | P25929 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 1/20 | 0.45 |
| ▸ | NPY4R | P50391 | 1/20 | 0.45 |
| ▸ | MME | P08473 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29611990 | 0.99 | ERAP2 (0.49) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL31097668 | 0.94 | FOLH1 (0.55) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL30528151 | 0.94 | FOLH1 (0.55) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL31097736 | 0.94 | FOLH1 (0.55) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL30943426 | 0.94 | ERAP2 (0.46) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL31097674 | 0.94 | FOLH1 (0.55) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL30785147 | 0.93 | ERAP2 (0.55) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL29714947 | 0.93 | ERAP2 (0.55) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL29760953 | 0.92 | ERAP2 (0.53) | ERAP2ERAP1LNPEPFOLH1CPB2 | |
| SCHEMBL29666891 | 0.92 | ERAP2 (0.54) | ERAP2ERAP1LNPEPFOLH1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4618957-A1 | COMPOSITIONS COMPRISING OCTADECANEUROPEPTIDES (ODN) AND SYNTHETIC DERIVATIVES THEREOF AND METHODS OF USE FOR MODULATION OF FOOD INTAKE, OBESITY, BODY WEIGHT, NAUSEA, AND EMESIS | The Trustees of The University of Pennsylvania (US) | 2025-09-24 | — | — | EP | disclosed |
| CN-118979089-A | Method for preparing lactoferrin active peptide by double enzymolysis and application thereof | 福州大学 | 2024-11-19 | — | — | CN | disclosed |
| WO-2024108216-A1 | COMPOSITIONS COMPRISING OCTADECANEUROPEPTIDES (ODN) AND SYNTHETIC DERIVATIVES THEREOF AND METHODS OF USE FOR MODULATION OF FOOD INTAKE, OBESITY, BODY WEIGHT, NAUSEA, AND EMESIS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-05-23 | — | — | WO | disclosed |